Metabolic syndrome and vascular risk in patients with peripheral arterial occlusive disease
Anne L M Vlek1, Yolanda van der Graaf, Maayke A Sluman
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Insights
The metabolic syndrome significantly increases vascular event risk in peripheral arterial occlusive disease (PAOD) patients. Weight management is key to reducing metabolic syndrome incidence and promoting its resolution, improving cardiovascular outcomes.
Area of Science:
- Cardiology
- Metabolic Diseases
- Vascular Medicine
Background:
- Peripheral arterial occlusive disease (PAOD) carries a high risk of cardiovascular events.
- Metabolic syndrome is common in vascular disease patients, but its impact on cardiovascular events in PAOD is not well understood.
- The dynamics of metabolic syndrome progression and regression in PAOD patients require further study.
Purpose of the Study:
- To investigate the influence of metabolic syndrome on cardiovascular event risk in patients with symptomatic PAOD.
- To examine the progression and regression of metabolic syndrome during follow-up in this patient cohort.
- To assess the role of body mass index (BMI) in the development and resolution of metabolic syndrome.
Main Methods:
- A cohort of 461 symptomatic PAOD patients from the SMART study were analyzed.
- Vascular screening was performed at baseline and after a mean follow-up of 5.5 years.
- Cox regression analysis was used to calculate hazard ratios for vascular events based on metabolic syndrome status (NCEP criteria).
Main Results:
- The metabolic syndrome was associated with a 1.5-fold increased risk of vascular events (HR 1.51).
- A decrease in BMI by 1 kg/m(2) significantly reduced the risk of developing metabolic syndrome (OR 0.77) and increased resolution (OR 1.32).
- During follow-up, metabolic syndrome resolved in 16% and newly developed in 14% of patients.
Conclusions:
- Metabolic syndrome is a significant risk factor for vascular events in PAOD patients.
- Weight control, indicated by BMI reduction, is crucial for decreasing metabolic syndrome incidence and promoting its resolution.
- Interventions targeting weight management may improve cardiovascular outcomes in PAOD patients with metabolic syndrome.
Objectives:
Peripheral arterial occlusive disease (PAOD) is associated with a high risk of cardiovascular events. The metabolic syndrome is a frequent condition among patients with manifest vascular disease, but the influence of the metabolic syndrome on cardiovascular events in patients with PAOD is unknown. Also, progression and regression of the metabolic syndrome after follow-up are not extensively studied.
Methods:
The study population consisted of 461 patients with symptomatic PAOD from the Second Manifestations of Arterial Disease study (SMART). Patients underwent vascular screening at baseline and after a mean follow-up of 5.5 +/- 1.3 years. Hazard ratios (HRs) for vascular events according to metabolic syndrome status (updated National Cholesterol Education Program [NCEP] criteria) were calculated using Cox regression analysis. The course of the metabolic syndrome during follow-up and the influence of body mass index (BMI) on development or disappearance of the syndrome were assessed.
Results:
During follow-up, 91 first vascular events were recorded. Cumulative 3-year survival free from vascular events was 84.7% in metabolic syndrome patients compared to 92.1% in participants without the syndrome. The metabolic syndrome was associated with an increased risk of vascular events (HR 1.51; 1.01-2.30, age- and gender-adjusted). During follow-up, 128 patients died or were lost to follow-up, and of 333 remaining patients, 221 participated in follow-up measurements. The metabolic syndrome disappeared in 16% of patients and was incident in 14% of patients during follow-up. Waist circumference increased with 10 +/- 8 cm in those developing the syndrome. A BMI decrease of 1 kg/m(2) significantly decreased the risk of metabolic syndrome development by 23% (odds ratio [OR] 0.77; 0.62-0.96), and increased the chance to revert to a non-metabolic syndrome state by 32% (OR 1.32; 1.03-1.71).
Conclusion:
The metabolic syndrome is associated with a 1.5-fold increase in risk of vascular events in PAOD patients. Weight control reduces metabolic syndrome incidence and increases metabolic syndrome resolution during follow-up.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Coronary Artery Disease I: Introduction

